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Analysis of the amplitude of low frequency BOLD signal fluctuations (ALFF) in the resting
state has recently been used to study the dynamics of intrinsic neural activity. Several
studies have also suggested its potential as a biomarker for neuropsychiatric disease. In
the current study, we quantified ALFF to determine changes in intrinsic neural oscillations
in patients with Parkinson’s disease (PD) on and off L-DOPA. Twenty-four PD patients
and 24 healthy age-matched controls participated in the study. PD patients underwent
two resting state fMRI sessions, either ON a controlled dose of L-DOPA or following a
placebo pill (OFF). Control participants underwent one test session. We found that there
was increased amplitude of low frequency BOLD signal oscillations for PD patients OFF
L-DOPA in the primary and secondary motor areas, and in the middle and medial prefrontal
cortices. L-DOPA significantly reduced the amplitude of low frequency oscillations within
these regions. The degree of ALFF in the premotor cortex predicted patients’ motor
performance as measured by the Grooved Pegboard task, such that greater ALFF was
associated with poorer performance. These results are in line with the pathophysiology
of PD, which shows changes in neural oscillations. Thus, frequency domain analyses of
resting state BOLD fMRI signals may provide a useful means to study the pathophysiology
of PD and the physiology of the brain’s dopaminergic pathways.
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INTRODUCTION
Parkinson’s disease (PD) is a progressive neurodegenerative dis-
order associated with loss of dopaminergic neurons in the sub-
stantia nigra pars compacta and the ventral tegmental area with
degeneration of the striatal nerve terminals (Bernheimer et al.,
1973; Kish et al., 1988; Frey et al., 1996; Rakshi et al., 1999; Braak
et al., 2006). One consistent pathophysiological hallmark of PD
is a change in spontaneous neural oscillations across the corticos-
triatal networks (Schnitzler and Gross, 2005; Gatev et al., 2006;
Berendse and Stam, 2007; Hammond et al., 2007; Timmermann
and Fink, 2009). Several studies show changes in low frequency
neural oscillations (0.3–2.5Hz) in rodent models of PD (Magill
et al., 2001; Tseng et al., 2001; Belluscio et al., 2003; Walters et al.,
2007). These studies have shown elevation of synchronous acti-
vation between cortical and basal ganglia neurons (Tseng et al.,
2001) or an augmentation of oscillatory activity within basal gan-
glia nuclei (Magill et al., 2001; Belluscio et al., 2003; Walters et al.,
2007) at low frequencies. Parallel results are reported in human
patients using EEG or MEG. PD associated changes in EEG sig-
nal oscillations are found in a range of frequencies. For example,
patients showed a widespread slowing of oscillatory brain activity
reflected as an increase in the power of neural activity at the low
frequency ranges such as the theta and low alpha bands (Soikkeli
et al., 1991; Bosboom et al., 2006; Stoffers et al., 2007;Moran et al.,
2008). Other studies show prominent increases in beta band oscil-
lations (Kuhn et al., 2004, 2006; Foffani et al., 2005) which are
suppressed by dopaminergic treatments (Brown et al., 2001; Levy
et al., 2002).
Changes in neural oscillations are associated with symptoms
of PD. One of the prominent symptoms reflected in oscilla-
tory activity is resting tremor. Significant coherence between
tremor frequency (3–7Hz) or its harmonic detected by EMG
with the EEG or MEG signal from the contralateral hemi-
sphere has been reported in several studies (Volkmann et al.,
1996; Hellwig et al., 2000, 2001; Moran et al., 2008; Raethjen
et al., 2009). Other studies have shown that the increase in sub-
cortical oscillatory activity and intracortical coupling of neural
activity are correlated with disease severity (Silberstein et al.,
2005; Berendse and Stam, 2007; Stoffers et al., 2007; Stam,
2010).
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In a recent study we found changes in cortico-striatal func-
tional connectivity in PD patients using resting state functional
connectivity MRI (fcMRI; Kwak et al., 2010). In PD patients
we found an overall increase in the strength of corticostriatal
functional connectivity, and L-DOPA alleviated these effects by
decreasing connectivity strength. We interpreted these results as
enhanced regional coupling of neural activation associated with
the elevated synchronous neural oscillations in PD. However, it
is not clear whether these changes in the resting state BOLD
signal are confined to the corticostriatal circuitry. Although func-
tional connectivity analysis can provide us with information
on brain regions within particular networks, it does not reveal
spontaneous BOLD signal changes across the whole brain. It
is also unknown whether the resting state BOLD signal shows
increased oscillations, parallel to what has been observed with
EEG or MEG.
We addressed these issues in the current study by comparing
the magnitude of resting state BOLD signal oscillations in PD
patients ON and OFF L-DOPA and healthy age-matched con-
trols using the amplitude of low frequency fluctuations (ALFFs).
Developed by Zang et al. (2007), this approach involves the
spectral decomposition of the time series data with a focus on
amplitude in the low frequency domain relevant to the hemo-
dynamic response function (i.e., below 0.08Hz). The fractional
ALFF (fALFF) is used as a normalized index of ALFF by provid-
ing the relative amplitude of the low frequency domain against
the whole spectrum of frequencies (Zou et al., 2008). ALFF/fALFF
gives the power of signal fluctuations, and thus indicates how
much BOLD signal oscillation there is in a given region at rest.
Because ALFF can be used to study the magnitude of the low fre-
quency BOLD signal oscillations in a voxel-wise fashion across
the whole brain, using this approach allows us to test the regional
specificity of PD and L-DOPA effects on spontaneous BOLD
signal oscillations.
Calculations of ALFF have recently gained much interest to
study the dynamics of intrinsic brain activity (Yang et al., 2007;
Biswal et al., 2010; Zuo et al., 2010). Furthermore, numerous
studies have demonstrated changes in ALFF for neurological and
psychiatric diseases (Zang et al., 2007; Hoptman et al., 2010;
Huang et al., 2010; Liu et al., 2010, 2011; Lui et al., 2010; Zhou
et al., 2010; Han et al., 2011). For example an increase in putamen
ALFF has been reported in patients with paroxysmal kinesigenic
choreoathetosis, which is a rare neurological condition where spe-
cific movements can induce dyskinesias (Zhou et al., 2010). For
Schizophrenia, there have been reports of decreased ALFF in the
medial prefrontal lobe and increased ALFF in the bilateral puta-
men (Huang et al., 2010). There have been two recent studies
showing PD associated changes in ALFF (Skidmore et al., in press-
a,b). These studies demonstrated that there are significant ALFF
changes in a number of brain regions which reliably separate PD
from healthy controls (Skidmore et al., in press-b). Furthermore,
the ALFF measures correlated with apathy, depression and motor
symptom severity in PD (Skidmore et al., in press-a). While these
studies investigated disease effects, they did not evaluate changes
in ALFF with anti-Parkinsonian medication.
Not many studies have approached ALFF with a clear hypoth-
esis on the direction of change (i.e., whether a certain patient
group will have higher or lower ALFF power) or what neural
implications (i.e., whether it reflects signal oscillations at the neu-
ronal level or whether it is just another index of resting state
BOLD activity) ALFF power has. This is because it is a relatively
newly developed measure. The current study extends efforts to
understand the neural implications of ALFF by studying the PD
population, in which abnormalities in neural oscillations have
been identified. Based on prior neurophysiological investigations
on PD, we hypothesized that there will be an increase in ALFF
power for PD patients particularly in the corticostriatal network.
More importantly we also investigated the effect of L-DOPA
on ALFF measures, which allows us to determine whether the




The data set collected from 24 mild to moderate stage (Hoehn
and Yahr stages 1–2.5; Hoehn and Yahr, 1967) PD patients
(64 ± 8 years, two females) and 24 age- and gender-matched
healthy controls (63 ± 7 years, five females) as part of a pre-
vious project (Kwak et al., 2010) was included in this study.
Patients were evaluated using the motor section of the Unified
Parkinson’s Disease Rating Scale (UPDRS; Fahn et al., 1987).
The more disease affected body side was determined by ask-
ing each PD patient and was confirmed by the UPDRS rating.
All study participants underwent the Mini-Mental State Exam
(MMSE; Folstein et al., 1975), the Montreal Cognitive Assessment
(MOCA; Nasreddine et al., 2005) and the grooved pegboard test
(Lafayette Instruments, Lafayette, IN) to measure general cogni-
tive and psychomotor abilities. These clinical assessments were
acquired for patients in both ON and OFF medication states.
The demographic and clinical characteristics of the patients are
listed in Table 1. Participants signed a consent form approved
by the Institutional Review Board of the University of Michigan
prior to the experiment, and were compensated for their partic-
ipation. All experimental procedures were conducted in accor-
dance with the Institutional Review Board of the University of
Michigan.
PROCEDURE
PD patients completed two testing days corresponding to the
ON and OFF medication states. Thirteen patients were tested
ON first and 11 OFF first. Patients attended both testing days
after withdrawal from medication for 12–18 h. Patients received
a 50mg dose of carbidopa followed by either a single dose of
L-DOPA (ON) or placebo (OFF) in combination with 50mg car-
bidopa (200mg of L-DOPA/placebo and an additional 50mg of
carbidopa). All study procedures began 1 h after the patient had
taken either L-DOPA or the placebo, by which time L-DOPA
reaches its peak plasma dose. Patients were first assessed with the
UPDRS (10min), after which the resting fMRI scan was done
(8min) followed by an additional fMRI session not discussed in
this paper (20min). All other behavioral assessments including
MMSE, MOCA and the grooved pegboard were done afterwards
(10min). Control participants underwent a single testing session
without any medication procedure.
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Table 1 | Demographic and clinical variables of the Parkinson’s patients.
Age M/F Disease Affected H&Y UPDRS_ON UPDRS_OFF MMSE_ON MMSE_OFF MOCA_ON MOCA_OFF
duration body
(years) side
PD_01 62 M 6 R 2.5 15 16 28 27 29 25
PD_02 70 M 8 L 2 23 19 28 28 27 30
PD_03 70 M 7 R 2 14 21 28 27 28 28
PD_04 52 M 6 R 2.5 16 20 30 30 26 30
PD_05 71 M 13 R 2.5 18 24 29 29 28 29
PD_06 69 M 12 R 2 20 24 30 30 30 27
PD_07 60 M 3 R 1.5 10 9 30 29 30 27
PD_08 65 M 8 R 2.5 21 27 29 30 27 28
PD_09 63 M 7 L 2.5 28 28 30 30 26 28
PD_10 69 M 9 R 2 24 23 29 29 22 22
PD_11 66 M 1 L 2 9 9 29 29 27 26
PD_12 67 M 9 R 2.5 14 14 27 27 27 28
PD_13 73 M 2 R 2.5 18 14 29 29 22 24
PD_14 51 M 2 R 2 9 8 30 29 30 27
PD_15 68 M 2 L 2 25 27 29 28 27 25
PD_16 72 M 4 L 2.5 27 26 27 28 21 25
PD_17 59 F 2 R 2 5 6 29 28 27 25
PD_18 64 M 7 R 2 8 6 28 29 18 20
PD_19 64 M 3 L 2 28 30 28 28 28 28
PD_20 80 M 6 R 2 11 13 27 28 29 27
PD_21 50 M 3 R 1.5 13 13 29 30 24 22
PD_22 62 M 2 R 2 10 17 29 28 26 25
PD_23 51 M 3 R 2.5 32 37 30 28 25 26
PD_24 55 F 3 R 2 15 14 29 30 22 24
Mean_PD 64.3 ± 8 5.4 ± 3 2.2 ± 0.3 17.3 ± 8 18.5 ± 8 28.8 ± 1 28.8 ± 1 26 ± 3 26 ± 3
Mean_Control 63.3 ± 7 29.1 ± 1 25.7 ± 3
fMRI DATA ACQUISITION
FMRI data were collected from a 3T GE Signa MRI scanner.
We acquired 240 T2∗ - weighted BOLD images (TR = 2 s,
TE= 30ms, flip angle= 90◦, FOV= 220 × 220mm, voxel size =
3.4× 3.4× 3.2mm, 40 axial slices) for 8min during rest. A 3D T1
axial overlay (TR = 8.9ms, TE= 1.8ms, flip angle = 15◦, FOV =
260 × 260mm, slice thickness = 1.4mm, 124 slices; matrix =
256 × 160) and T1-weighted anatomical image using spoiled
gradient-recalled acquisition (SPGR) imaging (flip angle=15◦,
FOV = 260 × 260mm, 1.4mm slice thickness) were acquired.
A pressure belt was placed around the abdomen to monitor the
respiratory signal. A pulse oximeter was placed on the finger to
monitor the cardiac signal. We did not separately monitor tremor
during the fMRI scan.
fMRI DATA ANALYSIS
The resting state fMRI data were preprocessed as follows: (1)
k-space outliers were replaced with the average of their temporal
neighbors, (2) images were reconstructed using field map cor-
rection, (3) physiological variations in the data from the cardiac
and respiratory rhythms were regressed out, (4) images were slice
timing and motion corrected. The preprocessed data were then
normalized to MNI space using SPM5 (Wellcome Department of
Cognitive Neurology, London, UK; http://www.fil.ion.ucl.ac.uk).
In order to have all of the PD patients’ predominantly disease
affected hemisphere aligned, we flipped the x direction (i.e., left–
right direction) of both the 240 functional images and the T1
anatomical images for the six left side more affected patients. The
results are presented with the left side of the images reflecting
patients’ more affected brain hemisphere. The same proportion
of control subject images was also flipped in the x direction.
Functional images were spatially smoothed using a full width at
half-maximum 8mm Gaussian smoothing kernel.
The amplitude of spontaneous low-frequency fluctuations
within the resting state fMRI time course was examined with
ALFF and fALFF. For the purpose of conciseness, only the
results of analyses conducted with ALFF are presented here.
The fALFF results are presented in the Appendix. The time
course data in each voxel was transformed into the frequency
domain using fast-Fourier transformation. For ALFF, the sum
of amplitudes within a specific low-frequency range (0–0.08Hz)
was computed at each voxel. fALFF, which is the ratio of the
amplitude in a low-frequency band to amplitude in the total
frequency band was computed by dividing the ALFF value by
the total sum of amplitudes across the entire frequency range.
ALFF and fALFF maps were Z-transformed by subtracting the
mean voxel-wise ALFF or fALFF for the individual’s entire
brain, and dividing by the corresponding standard deviation. The
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individual Z-transformed ALFF and fALFF maps were carried
forward to the group-level random effects analyses conducted
with SPM5.
To determine L-DOPA effects on ALFF/fALFF in PD patients,
we performed our analysis in the following fashion. First we
compared PD OFF ALFF/fALFF maps to controls and to PD
ON within anatomically defined ROIs comprised of the corti-
cal motor areas, the prefrontal cortex (PFC), and the striatum.
The PD ON data were also compared to controls to determine
whether L-DOPA normalizes the altered resting state oscillations.
A combination of M1, SMA, pre-SMA, and the dorsal and ven-
tral premotor areas from the human motor atlas (Mayka et al.,
2006) was used as the motor cortical ROI. A combination of the
superior, middle, inferior and medial frontal gyri from the WFU
PickAtlas software (Maldjian et al., 2003) was used as the PFC
ROI. The caudate and putamen from the WFU PickAtlas software
(Maldjian et al., 2003) were used as the striatal ROI. Each ROI
encompassed both the left and right hemispheres. ROIs were used
in the between group comparison using p < 0.005, uncorrected
with an extent threshold of 20 voxels. Bonferroni corrections for
multiple ROI comparisons were applied (0.005/3 ROIs), yielding
a corrected threshold of p < 0.0017.
To determine whether L-DOPA normalizes PD associated
changes, we also compared the ALFF/fALFF amplitudes between
PD OFF versus PD ON and PD ON versus controls in the brain
regions identified from the PDOFF versus control group compar-
ison. The mean ALFF/fALFF amplitude across all voxels within
the identified clusters was compared between PD OFF and PD
ON and between PD ON and controls using repeated measures
ANOVA. Medication status (i.e., PD OFF vs. PD ON) and ROI
were used as within subject factors for the ON and OFF compar-
ison and group (i.e., PD ON vs. controls) was used as a between
subject factor and ROI as a within subject factor in the sec-
ond comparison. In cases where the sphericity assumption was
not met, the F statistic was evaluated for significance using the
Huynh–Feldt adjusted degrees of freedom (Huynh and Feldt,
1970).
To determine whether PD-associated changes in ALFF/fALFF
amplitudes have clinical implications, we explored correlations
between the PD OFF ALFF/fALFF power of the regions iden-
tified from the PD OFF versus control group comparison and
the clinical assessments. Mean ALFF/fALFF amplitude across all
voxels within the identified cluster in PD OFF was used in this
correlation analysis.
Lastly, exploratory whole brain comparisons of ALFF/fALFF
maps were performed between the three groups using uncor-
rected p < 0.001 with an extent threshold of 20 voxels.
RESULTS
BEHAVIORAL DATA GROUP COMPARISONS
There were no statistically significant age differences between PD
patients and controls. Patients’ performance on MMSE, MOCA
and grooved pegboard tests ON and OFF L-DOPA states were
compared to controls. Neuropsychological assessments were not
performed for one control participant. In patients both ON
and OFF L-DOPA performance on MMSE and MOCA did not
differ from controls. Patients’ grooved pegboard performance was
worse than controls in both ON and OFF states for both the right
and left hands (controls vs. PD ON: [t(31.60) = 3.34, p < 0.005],
right hand, [t(27.10) = 4.3, p < 0.001], left hand, controls vs.
PD OFF: [t(29.49) = 3.9, p < 0.005], right hand, [t(26.77) = 4.47,
p < 0.001], left hand). We also compared patients’ performance
on the UPDRS, MMSE, MOCA, and grooved pegboard tests
between the ON and OFF L-DOPA states using paired t-tests.
No significant differences between medication states were found
for MMSE orMOCA scores. Pegboard performance was analyzed
separately for the more and less affected sides. Motor symp-
toms measured by UPDRS only showed a trend to be worse
in PD OFF than PD ON [t(23) = −2.0, p = 0.055], and peg-
board performance for the more affected side was significantly
worse for PD OFF than PD ON [t(23) = −2.61, p < 0.05] but not
for the less affected side. These results indicate that the patient
group was comparable to controls in their general cognitive func-
tions as shown by no significant group difference in MMSE
and MOCA. However the results indicate that patients were
impaired in manual motor performance compared to controls as
shown by the difference in pegboard performance. Additionally
the comparisons between PD ON and PD OFF indicate
that L-DOPA significantly improved motor functioning of the
patients, and the improvement was most apparent for the more
affected side.
COMPARISON OF ALFF ACROSS GROUPS: ROI ANALYSIS
We first compared the ALFF map of PD OFF to controls. We
found that there was an overall increase in ALFF power in PDOFF
compared to controls. In particular, ALFF power was increased in
the primary and secondarymotor areas (BA 6), the middle frontal
gyrus (BA 8) of the less affected hemisphere and the medial
frontal gyrus (BA 32) of the more affected hemisphere (Figure 1
and Table 2). There were no regions showing greater ALFF power
in controls than PD OFF.
We then compared the ALFF map of PD OFF to PD ON
and found that L-DOPA significantly reduced ALFF power in PD
patients. These effects were most prominent in the prefrontal (BA
8 and 10) and motor cortical areas (BA 6; Figure 1 and Table 2)
and were more evident in the more affected hemisphere. There
were no regions showing L-DOPA associated increases in power.
We also compared PD ON to controls to determine whether
L-DOPA normalizes PD-associated changes in low frequency
oscillations. We found that some regions exhibited increased
ALFF power and others decreases for PD ON compared to con-
trols. Whereas the pre-supplementary motor area of the less
affected hemisphere showed increases in PD ON, the thalamus
of the more affected hemisphere and the middle frontal gyrus of
both hemispheres (BA 8) showed decreases in ALFF power for PD
ON compared to controls (Figure 1 and Table 2).
To determine whether the PD-associated increase in ALFF
power is down-regulated by L-DOPA, we performed an addi-
tional ROI analysis comparing the ALFF power between PD OFF
and PD ON and between PD ON and controls within the regions
that were identified as exhibiting greater ALFF for PD OFF rel-
ative to controls. A comparison between PD OFF and PD ON
using a medication status (i.e., PD OFF vs. PD ON) by ROI (i.e.,
precentral vs. premotor vs. mid_frontal_g vs. ACC, see Table 2.
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PD OFF > Controls PD OFF > PD ON
PD ON > Controls Controls > PD ON
FIGURE 1 | Comparison of ALFF between groups within the predefined ROIs of the cortico-striatal network. No significant results were found for
controls > PD OFF or PD ON > PD OFF contrasts. P < 0.0017 based on correction.
Table 2 | Brain regions where group differences in ALFF were found using the ROI analysis.
Side (M/L) BA Coordinates T value
x y z
OFF > CONTROLS
Precentral gyrus L 6 52 −4 42 4.28
Precentral gyrus (premotor) L 6 52 4 32 3.61
Middle frontal gyrus L 8 30 0 46 3.94
Medial frontal gyrus (ACC) M 32 −10 14 46 3.92
OFF > ON
Precentral gyrus (premotor) M 6 −52 6 30 5.28
Medial frontal gyrus (SMA) M 6 −6 −2 64 4.64
Middle frontal gyrus M 8 −44 24 40 4.67
Middle frontal gyrus L 8 36 26 38 3.61
Medial frontal gyrus M 8 −4 38 38 4.28
Medial frontal gyrus M 10 −10 52 16 3.82
ON > CONTROLS
Superior frontal gyrus (pre-SMA) L 6 20 28 62 3.99
CONTROLS > ON
Thalamus (VPM) M −16 −22 2 4.08
Middle frontal gyrus L 8 32 24 38 4.06
Middle frontal gyrus M 8 −36 24 40 3.58
M/L refers to more and less affected sides, BA to Brodmann’s area.
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PD OFF > Controls for clusters used as ROIs) repeated mea-
sures ANOVA showed a main effect of medication status showing
overall decreases in average ALFF power across the four ROIs
[F(1, 23) = 6.29, p < 0.05, Figure 2]. There was also a main effect
of ROI [F(2.02, 46.40) = 14.94, p < 0.001]. No significant inter-
action was found. A comparison between PD ON and controls
using a group (i.e., PD ON vs. control) by ROI repeated mea-
sures ANOVA also showed a main effect of group [F(1, 46) = 5.17,
p < 0.05] and a main effect of ROI (F(3, 138) = 23.76, p < 0.001).
No significant interaction was found.
ALFF CORRELATIONS WITH BEHAVIORAL METRICS IN PD
We explored correlations between the PD-related changes in
ALFF power (regions showing a difference between PD OFF and
controls listed in Table 2) with grooved pegboard based on the
observation that performance differed between patients and con-
trols. The UPDRS score was also used in the correlation analysis
considering its significance in disease rating. Mean ALFF power
across all voxels for each of the four cluster regions and the clinical
variables from patients in the OFF state were used. We only found
correlation between the ALFF power of the premotor cortex in the
less affected hemisphere and the more affected hand performance
on the grooved pegboard test. Poorer performance was associated
with higher ALFF power (r = 0.51, p = 0.012, Figure 3).
COMPARISON OF ALFF ACROSS GROUPS: WHOLE BRAIN
ANALYSIS
A comparison of whole brain ALFF maps between PD OFF and
controls showed elevated power in PD OFF predominantly in the
primary and secondary motor areas (BA 6), which was already
identified in the ROI analysis (Figure 4A and Table 3). The only
other brain region that showed greater power in PD OFF was the
inferior temporal gyrus. ALFF power was decreased in PD OFF
in the precuneus, cerebellum lobule V, and superior and middle





























FIGURE 2 | ALFF power comparison of PD ON to PD OFF and PD ON to
controls for brain regions identified in PD OFF > controls contrast.
L-DOPA significantly down-regulates the abnormally increased ALFF power
in PD as shown by the PD ON vs. PD OFF comparison. A difference in
ALFF power still existed after L-DOPA administration as shown by PD ON
vs. controls comparison. The negative y axis values (ALFF power z score)
indicate ALFF power lower than the mean of the whole brain. ACC, anterior
cingulate cortex; Mid_F_G, middle frontal gyrus; M1, precentral gyrus.
A comparison of whole brainALFFmaps between PDOFF and
PD ON showed decreased power in PD ON in multiple regions
within the PFC (BA 6, 8, 9, 10, 32, and 44) that were already iden-
tified in the ROI analysis, as well as in the postcentral gyrus (BA
1/2; Figure 4B and Table 3). ALFF power was increased in PD
ON compared to PD OFF in the middle and inferior temporal
gyri, the occipital and fusiform gyri and cerebellum lobules V and
X (Figure 4B and Table 3). A comparison of PD ON to controls
showed areas of increased ALFF power including the middle and
inferior temporal gyri, superior frontal (BA 6, 8) and fusiform
gyri and the cuneus (Figure 4C and Table 3) as well as decreased
power in the superior occipital, superior temporal, middle frontal
gyrus, thalamus and precuneus (Figure 4C and Table 3).
We also performed ROI analyses comparing the ALFF power
between PD OFF and PD ON and between PD ON and con-
trols within the regions that were identified as exhibiting differ-
ences between PD OFF relative to controls in the whole brain.
Two separate analyses were done for ROIs identified as show-
ing greater ALFF power in PD OFF than controls and for ROIs
identified as showing lower ALFF power in PD OFF than con-
trols. In the former, we used average ALFF power across the
whole cluster of pre-SMA, SMA, precentral gyrus and the infe-
rior temporal gyrus (ROI set 1, Figure 5A). In the latter we used
the average ALFF power of the precuneus, cerebellum, middle,
and superior temporal gyri (ROI set 2, Figure 5B, see Table 3
for the peak voxel coordinates of the ROI clusters used). A
repeated measures ANOVA comparing PD OFF and PD ON
across ROI set 1 showed a main effect of ROI [F(3, 69) = 18.4,
p < 0.0001] and a marginal group by ROI interaction effect
[F(3, 69) = 2.7, p = 0.05]. A follow up paired t-test comparing
each ROI between groups did not show group differences in
any of the ROIs. A repeated measures ANOVA comparing PD
OFF and PD ON across ROI set 2 only showed a ROI main
effect [F(3, 69) = 12.9, p < 0.0001]. A repeated measures ANOVA
comparing PD ON and controls across ROI set 1 showed a sig-
nificant main effect of group [F(1, 46) = 18.4, p < 0.0001], ROI
























LA_Premotor area ALFF power (BA 6)
FIGURE 3 | Correlation between ALFF of the premotor cortex in the
less affected hemisphere (LA) and performance on the grooved
pegboard task of the more affected body side (MA) in PD OFF. Greater
ALFF is associated with worse performance (i.e., slower movement).
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A B C
FIGURE 4 | Whole brain ALFF comparisons between groups. PD OFF > controls, red, PD OFF < controls, green (A), PD OFF > PD ON, red, PD OFF < PD
ON, green (B), PD ON > controls, red, PD ON < controls, green (C).
[F(1.5, 68.8) = 4.8, p < 0.05]. A follow up two sample t-test com-
paring each ROI between groups showed that while group dif-
ferences were found for the pre-SMA [t(46) = −2, p < 0.05],
precentral [t(46) = −3.5, p < 0.005] and inferior temporal gyrus
[t(28) = −3.2, p < 0.005], no group difference was found for the
SMA. A repeated measures ANOVA comparing PD ON and con-
trols across ROI set 2 showed a main effect of group [F(1, 46) =
60.5, p < 0.0001] and ROI [F(3, 138) = 14.4, p < 0.0001], and no
group by ROI interaction.
DISCUSSION
In the current study, we determined whether L-DOPA changes
the resting state low frequency BOLD signal oscillations in PD
patients. We hypothesized that L-DOPA would reduce the abnor-
mality of signal oscillations in PD patients. We found that there
was an abnormal elevation of ALFF power in PD specifically
within the primary and secondary motor regions and the PFC.
Individual differences in the ALFF measure predicted clinical
motor symptoms measured by Grooved Pegboard. This task has
been previously shown to be a sensitive index of the level of
nigrostriatal dopaminergic denervation in PD (Bohnen et al.,
2007). We found that the ALFF power in the premotor cortex
within PD patients explains some of the variance in pegboard per-
formance, which reflects striatal dopaminergic denervation and
thus, disease severity. That is, the greater the ALFF amplitude,
the worse the pegboard performance and thus symptom sever-
ity. It is of note that this relationship was found between the less
affected hemisphere and the more affected hand performance,
which suggests that the correlation we observed may not reflect
direct functional coupling between ALFF power and pegboard
performance. Furthermore, considering that the correlation did
not survive multiple comparison correction the result should be
interpreted with caution.
In our comparisons between PD OFF and PD ON and PD
ON and controls, we showed that L-DOPA significantly alleviated
the increased ALFF power in the primary and secondary motor
areas and the prefrontal regions. We also confirmed that L-DOPA
decreased ALFF power within the brain regions showing increases
in PD compared to controls, although there were still significant
differences from controls. The L-DOPA associated ALFF changes
revealed by the comparison of PD ON and PD OFF were more
prominent in the more disease-affected hemisphere. L-DOPA
has been shown to selectively increase synaptic dopamine in the
more denervated subregions of the striatum (Tedroff et al., 1996).
Additionally whereas the L-DOPA associated synaptic dopamine
increase is significant versus baseline in the more affected puta-
men, it was not in the less affected side (Tedroff et al., 1996). It
is possible that the controlled dose of L-DOPA we used primarily
affected the more denervated hemisphere, contralateral to most
Parkinsonian symptoms thereby changing the ALFF amplitude
to a greater extent in the more affected hemisphere. Collectively
these results suggest that L-DOPA modulates ALFF power, such
that it down-regulates the abnormally increased oscillation in the
BOLD signal in PD.
It is of note that the L-DOPA dosage we used did not effectively
alleviate motor symptoms as assessed by UPDRS, although there
was a trend and also a significant improvement in the Pegboard
performance. UPDRS was assessed after 1 h from either L-DOPA
or placebo administration, which is when the L-DOPA reaches
its peak plasma dose and its effect reaches the peak. Thus it is
not likely that the assessment was done after the L-DOPA effect
subsided. It is possible that the dosage we used may not have
been effective for all PD patients, since some of them were usu-
ally taking both L-DOPA and dopamine agonists or only agonists.
It is important to note that the changes in ALFF with L-DOPA
are found even when L-DOPA effects on symptom improvement
are not significant. This suggests that the neural effects we see
in ALFF could be capturing changes in the brain state prior to
symptomatic change.
Comparisons of ALFF maps between PD ON and controls
showed patterns of both increased and decreased power in PD
ON. It is possible that depending on the efficacy of the controlled
dose of L-DOPA for our patient group, it does not sufficiently
decrease the abnormal oscillations in some regions. This is also
supported by the still existing gap in ALFF power between con-
trols and patients even after L-DOPA administration. The results
also demonstrate that L-DOPA suppresses the oscillations even
beyond the normal range in some regions.
Although we found significant group differences in the pri-
mary and secondary motor areas and the prefrontal regions,
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Table 3 | Brain regions where group differences in ALFF were found with whole brain analysis.
Side (M/L) BA Coordinates T value
x y z
OFF > CONTROLS
Precentral gyrus L 6 42 −6 14 4.4
Inferior temporal gyrus L 20 54 −20 −18 4.2
Middle frontal gyrus (SMA) L 6 30 0 46 3.94
Medial frontal gyrus (pre-SMA) M 6 −10 14 46 3.92
CONTROLS > OFF
Precuneus M 7 −20 −74 52 4.6
Cerebellum (lobule V) M −6 −42 −36 4.18
Superior temporal gyrus M 38 −48 12 −8 4.12
Middle temporal gyrus M 21 −58 −36 −8 3.73
OFF > ON
Inferior frontal gyrus M 44 −52 6 30 5.28
Medial frontal gyrus (ACC) M 32 −2 8 42 5.06
Medial frontal gyrus M 8 −4 38 38 4.28
Postcentral gyrus M 1/2 −40 −26 40 4.74
Middle frontal gyrus M 9 −44 24 40 4.67
Superior frontal gyrus (SMA) M 6 −6 −2 64 4.64
Superior frontal gyrus M 10 −10 52 16 3.82
ON > OFF
Inferior temporal gyrus M 20 −36 −10 −30 6.44
Cerebellum (lobule V) M −34 −42 −28 5.25
Cerebellum (lobule X) L 26 −32 −44 4.64
Fusiform gyrus L 37 50 −54 −16 4.41
Middle temporal gyrus L 21 42 −10 −20 4.27
Occipital gyrus M 18 −22 −86 2 4.21
ON > CONTROLS
Inferior temporal gyrus L 20 56 −10 −32 4.55
Inferior temporal gyrus M 20 −46 −6 −30 4.07
Middle temporal gyrus M 21 −58 −18 −6 4.26
Superior frontal gyrus M 8 −6 48 54 4.18
Superior frontal gyrus (premotor) L 6 20 26 64 4.09
Fusiform gyrus M 20 −64 −24 −24 3.97
Cuneus M 17 −22 −86 8 3.92
CONTROLS > ON
Superior occipital gyrus L 19 20 −76 38 4.42
Superior temporal gyrus M 12 −50 10 −8 4.31
Thalamus (VPM) M −16 −22 2 4.08
Middle frontal gyrus L 9 32 24 38 4.06
Precuneus M 7 −14 −74 52 4.04
Precuneus L 7 2 −58 64 3.88
M/L refers to more and less affected sides, BA is Brodmann’s area.
which are the major cortical target of striatal output, we found
little effect in the striatum. The only striatal region we found was
in the caudate where fALFF power was increased in PD OFF com-
pared to PDON (see Appendix). A previous study has shown that
cortical regions show relatively higher f/ALFF power than subcor-
tical regions in the healthy brain (Zuo et al., 2010). We speculate
that group differences are better identified in cortical than in
subcortical regions because there is room for a wider range of
effects.
Our findings differ from those of a recent study comparing
ALFF between PD patients and controls (Skidmore et al., in
press-b). While this study did not test patients in the ON med-
ication state, the results showed that ALFF power was decreased
in patients relative to controls in a number of regions including
the supplementary motor cortex, the mesial PFC, and the middle
frontal gyrus (Skidmore et al., in press-b). The only brain region
that showed increased ALFF power in PD was the right cerebel-
lum. There are a number of methodological differences between
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FIGURE 5 | ALFF power of the three groups (i.e., PD ON, PD OFF, and
controls) for brain regions identified in PD OFF > controls contrast (A)
and in PD OFF < controls contrast (B) in the whole brain analysis.
our study and theirs’, which may have led to the discrepancies.
First, we evaluated data from 24 patients while Skidmore et al.
(in press-a,b) included 15. Additionally in our study the more
and less disease affected hemispheres were aligned across patients
before statistical analysis as in our previous study (Kwak et al.,
2010). Furthermore, we acquired respiratory and cardiac signals
during scanning and regressed these signals out of the resting
state fMRI data, while Skidmore et al. (in press-a,b) regressed out
the full brain global mean signal. The latter has been shown to
dramatically shift the profile of resting state brain correlation pat-
terns (Murphy et al., 2009; Van Dijk et al., 2010) and may have
contributed to differences in the pattern of findings between the
two studies.
The current findings are in line with those of our recent
investigation comparing the strength of cortico-striatal functional
connectivity between PD patients ON andOFF L-DOPA and age-
matched controls (Kwak et al., 2010). The results also parallel the
findings of a recent fMRI study showing increased resting state
functional connectivity between the subthalamic nucleus and cor-
tical motor areas (BA 4/6) in PD (Baudrexel et al., 2011). The
enhanced low frequency BOLD signal oscillations in the motor
and prefrontal regions may underlie the increased functional
connectivity shown in these previous studies (Kwak et al., 2010;
Baudrexel et al., 2011), which parallels findings shown by oth-
ers using local field potential (LFP) and EEG/MEG recordings in
PD (Schnitzler and Gross, 2005; Gatev et al., 2006; Berendse and
Stam, 2007; Hammond et al., 2007; Timmermann and Fink, 2009;
Stam, 2010). However, there is not an obligatory link between
increased resting state BOLD oscillations and functional connec-
tivity; the latter would require an increase in synchronicity of the
BOLD signal across multiple regions.
The current work is closely related to our prior publication
using seed-based functional connectivity analysis (Kwak et al.,
2010). However the approach we take in the current study is dis-
tinctive from our previous study in the following ways: (1) While
in the previous study we looked at the degree of synchronous acti-
vation between striatal seed region time courses and voxel time
courses of the rest of the brain, in the current study we focused on
the intrinsic oscillations within a brain region. (2) With the seed-
based functional connectivity used in the previous study, we could
only look at changes in predetermined sets of networks (i.e., stri-
atal networks) whereas in the current study we looked at changes
across the whole brain by a voxel-wise comparison of ALFF power
of the whole brain. It should be stressed that correlation-based
functional connectivity and power frequency measurements give
different information about the low-frequency time courses; there
can be a change in power without a change in correlation, and
vice-versa. Thus, the prior seed-based work does not speak to
changes in ALFF power covered in the current work.
As suggested by prior studies, tremor can be reflected in neu-
ral oscillations (Volkmann et al., 1996; Hellwig et al., 2000, 2001;
Moran et al., 2008; Raethjen et al., 2009) and could be linked to
the changes we observe in ALFF in PD patients. A limitation of the
current study is that we did not have an online measure of tremor
during our scanning session. However, tremor was also not the
most significant symptom in most of our patients. The range of
UPDRS tremor scores across all of our subjects was 0–7 while the
score could range between 0 and 32. Eighteen out of 24 patients
had a score of 2 or lower. Thus based on the UPDRS tremor
score, it is unlikely that tremor significantly affected the degree
of ALFF. Moreover there was no significant difference between
tremor score ON and OFF, whereas significant differences in
ALFF were found in multiple regions of the brain. Head motion
inside the scanner reflects movement, and thus may also capture
tremor during the scan. We regressed out head motion prior to
data analyses. In order to determine whether ALFF is explained
by the degree of tremor measured by UPDRS, we explored corre-
lations between ALFF power of the four cluster regions identified
in the PD OFF vs. Controls comparison and the UPDRS tremor
score in both the OFF and ON state. UPDRS tremor score did
not correlate with ALFF power of any of the cluster regions for
patients in either the OFF or ON state. However, considering that
UDPRS tremor is not the most accurate measure of tremor and
since we did not acquire an online time course of tremor dur-
ing the scan, we cannot definitively conclude whether changes
in ALFF reflect changes in neuronal oscillations associated with
tremor.
Whether or not the changes we observed in the very low
frequency oscillations of the BOLD signal is parallel to the
changes in neural oscillations found in prior LFP and EEG/MEG
studies in PD requires careful consideration. Because the
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BOLD signal is derived from the hemodynamic response, one
source of BOLD signal oscillation that may not be neurally driven
is that associated with the mechanical fluctuations of the cere-
bral vasculature. Studies have indeed found that BOLD signal
oscillations may contain properties of vascular oscillation (Strik
et al., 2002; Wise et al., 2004; Frederick et al., 2012). At the same
time however, these studies do not demonstrate that BOLD sig-
nal fluctuations are purely driven by the physical properties of the
vasculature. Even after removing the vasculature signals, BOLD
signal fluctuations demonstrate neuronal properties as shown by
the presence of previously identified functional networks. It is
of note that we cannot exclude the possibility that differences
in BOLD signal fluctuation between PD patients and controls
or between L-DOPA states are primarily driven by differences
in non-neuronal vascular oscillation as dopamine affects cere-
bral vascular properties (Gleason et al., 2002). Thus our results
should be interpreted carefully considering the contribution of
dopamine to cerebral vasculature. Future studies are warranted
to address this issue by measuring BOLD and vascular properties
independently in dopamine ON and OFF states.
It is important to note that the current study does not aim to
identify the frequency range of BOLD oscillations with that of the
signal from the microcircuit level. BOLD fMRI is a hemodynamic
proxy for and an aggregate representation of the underlying
neural activities, which may oscillate in different frequencies.
Simultaneous intra-cortical recordings and fMRI have demon-
strated that the BOLD signal correlates with different types of
neural activity such as LFPs, multi-unit activity and single-unit
activity in multiple different frequency ranges such as delta, theta,
alpha, and gamma bands (Logothetis et al., 2001; Goense and
Logothetis, 2008). Simultaneous EEG and fMRI studies have also
shown that the EEG signal in these different frequency bands
collectively contributes to BOLD oscillations (Moosmann et al.,
2003; Laufs, 2008; de Munck et al., 2009; Britz et al., 2010; Musso
et al., 2010; Rosa et al., 2010). Thus the actual frequency range
for the BOLD signal (∼0.08Hz) may contain information from
neural activity in multiple different ranges, and not confined
to the frequency range we observed. To determine how neu-
ral signals from different frequency bands contribute to changes
in BOLD signal oscillations associated with PD and L-DOPA,
a combined EEG-resting state fMRI study in PD patients is
warranted.
In summary, we found L-DOPA associated changes in the
resting state low frequency BOLD signal oscillations within the
prefrontal and motor cortices, which are major cortical output
regions of the striatum. L-DOPA significantly reduced the PD-
associated abnormality in BOLD signal oscillations. These results
have significant implications for understanding pathological neu-
ral oscillations in PD. This study suggests that resting state BOLD
signal oscillations may provide a useful means to study the patho-
physiology of PD and the physiology of dopaminergic pathways
in healthy individuals.
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APPENDIX
COMPARISON OF fALFF ACROSS GROUPS: ROI ANALYSIS
We first compared the fALFF map of PD OFF to controls. Similar
to ALFF, we found increased fALFF power in PD OFF compared
to controls and there were no regions showing greater BOLD sig-
nal power in controls than PD OFF. fALFF power was increased
in the precentral gyrus of the less affected hemisphere (BA 6;
Figure A1 and Table A1).
Comparison of fALFF maps between PD OFF and PD ON
revealed some regions that showed decreased power but others
that showed increased power with L-DOPA. Whereas the sup-
plementary motor area (BA 6) of the less affected hemisphere
and the dorsolateral PFC (BA 9) and caudate nucleus of the
more affected hemisphere showed L-DOPA associated decreases
in fALFF power, the medial prefrontal (BA 10) and precentral
(BA 4) cortices of the less affected hemisphere showed L-DOPA
associated increases in fALFF power (Figure A1 and Table A1).
Comparison of fALFF maps between PD ON and controls
showed decreased fALFF power in the prefrontal regions (BA 8, 9,
11 and 47) of the more affected hemisphere in PD ON compared
PD OFF > Controls PD OFF > PD ON
PD ON > PD OFF Controls > PD ON
FIGURE A1 | Comparison of fALFF between groups within the predefined ROIs of the cortico-striatal network. No significant results were found for
controls > PD OFF or Controls > PD ON contrasts. P < 0.0017 based on correction.
to controls (Figure A1 and Table A1). There were no regions
showing increased fALFF power in PD ON versus controls.
Additional ROI analyses were performed to compare fALFF
power between PD OFF and PD ON and between PD ON and
controls within the regions that were identified as exhibiting
greater fALFF for PD OFF relative to controls. A paired t-test
comparing the average power of the precentral gyrus ROI between
PD OFF and PD ON showed a marginally significant difference
with decreased power in PD ON compared to PD OFF [t(23) =
1.81, p = 0.08, Figure A2]. An independent t-test comparing
PD ON and controls showed no significant difference in aver-
age fALFF power [t(46) = −1.55, p > 0.1]. PD-related changes in
fALFF power (relative to controls) did not show any correlations
with clinical variables.
COMPARISON OF fALFF ACROSS GROUPS: WHOLE BRAIN
ANALYSIS
fALFF map whole brain comparisons between the three groups
showed a similar pattern as the ALFF map comparisons
(Figure A3 and Table A2).
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Table A1 | Brain regions where group differences in fALFF were found using the ROI analysis.
Side (M/L) BA Coordinates T value
x y z
OFF > CONTROLS
Precentral gyrus L 6 58 −4 42 4.31
OFF > ON
Medial frontal gyrus (SMA) L 6 2 −18 78 4.88
Middle frontal gyrus M 9 −56 12 36 4.34
Caudate M −10 12 −2 4.29
ON > OFF
Medial frontal gyrus L 10 10 58 0 4.63
Precentral gyrus L 4 34 −26 60 4.17
Precentral gyrus L 4 58 4 16 3.7
CONTROLS > ON
Inferior frontal gyus M 11 −22 34 −20 4.17
Inferior frontal gyus M 47 −36 20 −2 3.74
Middle frontal gyrus M 8 −34 26 40 3.87
Superior frontal gyrus M 9 −42 44 32 3.74





























FIGURE A2 | fALFF power comparison of PD ON to PD OFF and PD ON to
controls for brain regions identified in PD OFF > controls contrast.
L-DOPA down-regulates the abnormally increased fALFF power in PD as
shown by the marginal difference in PD ON vs. PD OFF comparison.
Difference in fALFF power was no more present after L-DOPA administration
as shown by PD ON vs. controls comparison. M1, precentral gyrus.
A B Ca.
FIGURE A3 | Whole brain fALFF comparisons between groups. PD OFF > controls, red, PD OFF < controls, green (A), PD OFF > PD ON, red, PD OFF <
PD ON, green (B), PD ON > controls, red, PD ON < controls, green (C).
Frontiers in Systems Neuroscience www.frontiersin.org July 2012 | Volume 6 | Article 52 | 14
Kwak et al. L-DOPA effects on BOLD signal
Table A2 | Brain regions where group differences in fALFF were found with whole brain analysis.
Side (M/L) BA Coordinates T value
x y z
OFF > CONTROLS
Cuneus M 18 −8 −96 4 5.87
Inferior temporal gyrus L 20 54 −24 −14 5.85
Lingual gyrus L 18 18 −94 −12 5.64
Precentral gyrus L 6 58 −4 42 4.31
Cerebellum (lobule III) L 16 −40 −24 4.16
Cerebellum (lobule V) M −30 −30 −36 3.92
CONTROLS > OFF
Precuneus M 7 −16 −72 52 5.03
Superior occipital gyrus M 19 −42 −82 30 4.53
Inferior parietal lobule M 39 −60 −58 26 4.49
Superior parietal lobule L 7 14 −64 56 4.47
Inferior frontal gyrus M 47 48 20 0 3.9
OFF > ON
Middle frontal gyrus M 11 −18 38 −14 5.15
Middle frontal gyrus M 9 −56 12 36 4.34
Medial frontal gyrus L 6 2 −18 78 4.88
ON > OFF
Inferior temporal gyrus L 19 42 −70 0 5.11
Cerebellum (Cr I) L 16 −74 −38 4.96
cerebellum (Cr II) M −40 −60 −46 4.86
Cerebellum (lobule V) L 24 −28 −40 4.18
ON > Controls
Cuneus L 17 4 −94 6 5.94
Cerebellum (lobule X) L 26 −30 −42 4.86
Cerebellum (Cr I) L 40 −60 −36 4.7
Cerebellum (Cr V) L 16 −42 −24 4.48
Middle temporal gyrus L 21 58 −22 −12 4.46
Infereior temporal gyrus M 20 −28 −26 −34 4.34
Insula L 13 40 −6 6 3.98
CONTROLS > ON
Superior parietal lobule L 7 14 −64 54 4.59
Superior parietal lobule M 7 −38 −50 60 4.02
Precuneus M 7 −20 −76 50 4.4
Precuneus L 7 10 −36 44 3.99
Superior temporal gyrus M 38 −48 18 −38 4.37
Orbital gyrus L 11 8 42 −20 4.17
Middle frontal gyrus M 11 −22 34 −20 4.17
Inferior frontal gyrus M 47 −36 20 −2 3.74
M/L refers to more and less affected sides, BA is Brodmann’s area.
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